Audit 353257

FY End
2024-09-30
Total Expended
$2.04M
Findings
0
Programs
3
Year: 2024 Accepted: 2025-04-10

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

Contacts

Name Title Type
Q29GNV6KWAS4 Michael Warden Auditee
6573750502 Amanda Meko Auditor
No contacts on file

Notes to SEFA

Title: Basis of Presentation Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting in accordance with generally accepted accounting principles. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. De Minimis Rate Used: N Rate Explanation: CIBD has not elected to use the 10 percent de minimis indirect cost rate as allowed under the Uniform Guidance. The accompanying schedule of expenditures of federal awards (the Schedule) includes the federal grant activity of The Center for Comprehensive Care and Diagnosis of Inherited Blood Disorders (CIBD) for the year ended September 30, 2024. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations (CFR) Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Therefore, some amounts presented in this schedule may differ from amounts presented in, or used in the preparation of, the basic financial statements.